|
|
|
|
||||||||
|
Welcome to 4SC 4SC AG develops new drug candidates for the treatment of patients suffering from diseases with high medical needs. Since 15 December 2005 4SC AG has been listed in the Prime Standard Segment (regulated market) of the Frankfurt Stock Exchange.
|
|
|||||||||